Toggle navigation
Menu
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
73°
Search
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Local Weather
News
Sports
Entertainment
Calendar
Games
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Town & Gown
Subscribe
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Hikma Pharmaceutical
(OP:
HKMPF
)
31.38
USD
-1.22 (-3.75%)
Official Closing Price
Updated: 3:51 PM EST, Feb 26, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Hikma Pharmaceutical
< Previous
1
2
Next >
Hikma Donates Over $4 Million USD in Medicines and Signs New Long-term Partnerships with Dispensary of Hope, Direct Relief, Americares, Brother's Brother Foundation and the National Children's Cancer
February 18, 2021
Partnerships reinforce Hikma's commitment to supporting charitable organisations addressing unmet healthcare needs for underserved patients
From
PR Newswire
Hikma's commitment to environmental performance recognised with "A-" rating in 2020 CDP Global Climate Change Report
January 13, 2021
Improved rating elevates Hikma to global leadership position
From
PR Newswire
Hikma launches generic Advair Diskus® following FDA approval
December 17, 2020
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces it has received FDA approval for and launched its generic version of GlaxoSmithKline's Advair Diskus®1...
From
PR Newswire
Markets Up As US Clears Path For Moderna Vaccine Approval
December 16, 2020
European markets have opened positively this morning with Germany’s Dax leading the way up 1.6% as optimism creeps in surrounding vaccination and the prospect of US fiscal stimulus ahead of Central...
Tags
Financial
Cryptocurrencies
Technology
From
Blogs - TalkMarkets
Hikma and Arecor expand collaboration with new agreement to develop and commercialise ready-to-administer medicine
October 20, 2020
Adds ready-to-administer injectable product to companies' existing partnership
From
PR Newswire
Hikma receives favourable court ruling for its generic Vascepa®
September 03, 2020
Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, announces that the US Court of Appeals for the Federal Circuit today upheld a ruling by the US District Court for the...
From
PR Newswire
Hikma Ventures Participates in CAD4.0 million Series A Financing Round for SeamlessMD to Expand Digital Patient Engagement Leadership
August 26, 2020
Hikma Pharmaceuticals PLC (Hikma) announces that its venture capital arm, Hikma Ventures has participated in a CAD4.0 million Series A round of financing for SeamlessMD. The round was led by MEDTEQ,...
From
PR Newswire
Hikma launches Dicyclomine Hydrochloride Oral Solution
May 28, 2020
Receives first Competitive Generic Therapy Exclusivity from FDA
From
PR Newswire
Hikma receives FDA approval for generic of Amarin's Vascepa
May 22, 2020
Hikma Pharmaceuticals announced overnight that its wholly owned U.S. subsidiary Hikma Pharmaceuticals USA has received approval from the Food and Drug Administration for its Icosapent Ethyl Capsules,...
Tags
Stocks / Equities
Pharma/Biotech
From
Blogs - TalkMarkets
Hikma receives FDA approval for its generic Vascepa®
May 22, 2020
Hikma Pharmaceuticals PLC (Hikma), the multinational generic pharmaceutical company, today announces that its wholly owned U.S. subsidiary Hikma Pharmaceuticals USA Inc. has received approval from the...
From
PR Newswire
Is Amarin Stock a Buy?
May 19, 2020
Record revenues, international growth, and a potential legal strategy may provide upside.
Tags
Market News
SRPT
AMRN
From
Motley Fool
Hikma responds to COVID-19 shortage with launch of Propofol Injectable Emulsion, USP
May 12, 2020
Sedative for patients on ventilators currently in short supply in the US
From
PR Newswire
Hikma launches employee matching donation campaign to support local US food banks and pantries
May 11, 2020
Campaign will help address significant increase in demand caused by COVID-19 related job losses and furloughs
From
PR Newswire
Are Amarin's Blockbuster Dreams Over?
April 04, 2020
A ruling that invalidated Amarin’s patents means generic competition for its cardiovascular drug may be right around the corner.
Tags
AMRN
Market News
PFE
From
Motley Fool
Why Did Amarin's Stock Fall Off a Cliff?
April 02, 2020
Amarin's stock dropped 70% after its patent for Vascepa was invalidated by a federal judge.
Tags
RDY
HKMPF
Market News
From
Motley Fool
1 Cheap Biotech Stock to Buy
March 16, 2020
The market is in sell-off mode, but that doesn't mean you should stop buying stocks.
Tags
HKMPF
JAZZ
Market News
From
Motley Fool
Could Amarin Be a Millionaire Maker Stock?
January 28, 2020
Vascepa has a good chance of being a blockbuster, but an upcoming patent decision will have the final word.
Tags
AMRN
Market News
HKMPF
From
Motley Fool
Ternium SA Is A Strong Buy
January 15, 2018
Ternium, Orchid Island, and Mazda are "strong buy" stocks.
Tags
Stocks / Equities
From
Blogs - TalkMarkets
Hikma Announces Expanded Licensing Agreement with Takeda for New Products in the Middle East and North Africa
August 16, 2017
From
PR Newswire
News Beyond GSK R&D
November 05, 2015
Gold is flat on its back again, with no rise since the start of the year at $1115/oz. Oil meanwhile has gushed in price to $48.18/bbl, up nearly 4.5% just in time for a colder weather.
Tags
Stocks / Equities
From
Blogs - TalkMarkets
Step 9 - Financial Review
July 28, 2015
Microsoft is skipping from Windows 8 to Windows 10, and many people wonder what happened to number 9. I think I know; they replaced Windows 9 with Step 9, which requires them to make amends.
Tags
Services
Financial
Transportation
From
Blogs - TalkMarkets
Hikma Founder and Honorary Life President Samih Darwazah Passes Away
May 18, 2015
From
PR Newswire
UPDATE 1-Hikma profit jumps on strong injectible drugs sales
March 10, 2015
March 11 (Reuters) - Hikma Pharmaceuticals Plc reported a 21 percent rise in full-year pretax profit, helped by a stronger-than-expected performance at its high-margin injectible drugs business.
Tags
companyNews
From
Reuters: Company News
Hikma profit jumps on strong injectible drug sales
March 10, 2015
March 11 (Reuters) - Hikma Pharmaceuticals Plc reported a 21 percent rise in full-year pretax profit, helped by strong demand for its high-margin injectible drugs, particularly in the United States.
Tags
companyNews
From
Reuters: Company News
BRIEF-Hikma Pharma says preparing to distribute Colchicine
January 11, 2015
* Prepare to distribute its colchicine, which it will market under brand name mitigare
Tags
companyNews
From
Reuters: Company News
Hikma to Launch Colchicine 0.6mg Capsules
January 09, 2015
From
PR Newswire
PRESS DIGEST- Financial Times - Dec 22
December 21, 2014
Dec 22 (Reuters) - The following are the top stories in the Financial Times. Reuters has not verified these stories and does not vouch for their accuracy.
Tags
companyNews
From
Reuters: Company News
UPDATE 1-Hikma raises full-year revenue forecast
November 05, 2014
Nov 6 (Reuters) - Drugmaker Hikma Pharmaceuticals Plc raised its full-year revenue growth target to 7 percent, citing strong demand for its high-margin injectible drugs, particularly in the United...
Tags
companyNews
From
Reuters: Company News
BRIEF-Hikma says U.S. court grants temporary restraining order on co's Colchicine capsules
October 09, 2014
* Notes that us district court for district of delaware has granted takeda pharmaceuticals u.s. a motion for a temporary restraining order in relation to further distribution of hikma's fda-approved...
Tags
companyNews
From
Reuters: Company News
BRIEF-Hikma Pharma to buy Ben Venue's generic injectables factory
July 23, 2014
* Agreed with Ben Venue Laboratories, Inc. , part of Boehringer Ingelheim Group of companies, to acquire their generic injectables manufacturing site in Bedford, Ohio
Tags
companyNews
From
Reuters: Company News
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.